• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    March 11, 2025 - FDA Roundup: March 11, 2025

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $AMZN alert in real time by email
    For Immediate Release:
    March 11, 2025

    Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:

    • Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an increase in unreliable testing data from certain third-party testing labs. This has resulted in the FDA being unable to reach a substantial equivalence determination or otherwise authorize marketing for medical devices whose submissions rely on such data. Based on data analysis, the FDA determined that Mid-Link Technology Testing Co., Ltd., has in several instances, copied the results of another study or created falsified or otherwise invalid data that was submitted to the FDA. Until the firm adequately addresses these issues, all study data from all studies conducted at this testing facility will be rejected. Sponsors of device studies and manufacturers of devices are reminded to carefully evaluate the third parties they engage to conduct safety, performance, and cybersecurity testing and to independently verify all testing results before submitting to the FDA. The FDA remains committed to taking appropriate actions to address ongoing data integrity concerns.
    • Today, the FDA posted six warning letters to companies responsible for introducing unapproved fat dissolving injectable drug products into interstate commerce. The agency reminds consumers that fat-dissolving injections that are not FDA approved can be harmful. The letters were sent to: 
      • Amazon.com, Inc.
      • Fox Pharma LLC
      • Filler Lux dba Filler Lux USA
      • Hyaluron Pen Store, LLC dba Glow Nest Beauty
      • Julian Naya Beauty LLC
      • Vivid-Scientific LLC
    • On Friday, the FDA approved Omlyclo (omalizumab-igec) injection, for subcutaneous use to treat certain allergic, inflammatory, and autoimmune conditions. This is the first interchangeable biosimilar to Xolair (omalizumab). Omlyclo works by binding to immunoglobulin E (IgE), the antibody type that triggers allergic reactions, and blocks IgE from binding to its receptors. Omlyclo is administered subcutaneously for all indications but has different dosing instructions for each indication. More information about Omlyclo can be found in the full prescribing information.

    Related Information

    Related Information
    • FDA Newsroom 

    ###

    Boilerplate

    The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, radiation-emitting electronic products, and for regulating tobacco products.


    Inquiries

    Media:
    FDA Office of Media Affairs
    888-INFO-FDA
    Consumer:
    888-INFO-FDA

    Get the next $AMZN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMZN

    DatePrice TargetRatingAnalyst
    9/24/2025$280.00Equal Weight → Overweight
    Wells Fargo
    9/16/2025$250.00 → $270.00Buy
    Truist
    8/1/2025$260.00 → $280.00Overweight
    Cantor Fitzgerald
    8/1/2025$225.00 → $260.00Positive
    Susquehanna
    8/1/2025$230.00 → $265.00Buy
    DA Davidson
    8/1/2025$250.00 → $245.00Outperform
    Oppenheimer
    8/1/2025$262.00 → $260.00Buy
    Stifel
    8/1/2025$250.00 → $255.00Overweight
    Piper Sandler
    More analyst ratings

    $AMZN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Amazon upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Amazon from Equal Weight to Overweight and set a new price target of $280.00

    9/24/25 7:53:19 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Truist reiterated coverage on Amazon with a new price target

    Truist reiterated coverage of Amazon with a rating of Buy and set a new price target of $270.00 from $250.00 previously

    9/16/25 7:55:29 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Cantor Fitzgerald reiterated coverage on Amazon with a new price target

    Cantor Fitzgerald reiterated coverage of Amazon with a rating of Overweight and set a new price target of $280.00 from $260.00 previously

    8/1/25 11:06:40 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Water Environment Federation, Amazon, The Water Center at the University of Pennsylvania, and Leading Utilities of the World Launch Groundbreaking Water-AI Nexus Center of Excellence

    First-of-its-kind initiative to harness AI to solve critical water challenges New information released today on data center best-practices to minimize water impact in the age of AI NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Water Environment Federation (WEF), Amazon.com, Inc. (NASDAQ: AMZN), The Water Center at the University of Pennsylvania (WCP), and The Leading Utilities of the World (Leading Utilities) jointly announced today the creation of the Water-AI NexusTM Center of Excellence, a groundbreaking collaboration that will develop sustainable water practices for AI infrastructure while also using AI to solve global water challenges. This knowledge hub at the confluence of water and A

    9/25/25 8:30:00 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    AWS and SAP Expand Collaboration to Advance Digital Sovereignty Across Europe

    New sovereign cloud collaboration combines SAP enterprise applications expertise with AWS cloud infrastructure, enabling customers in highly regulated industries to pursue AI innovation Amazon Web Services (AWS), an Amazon.com company (NASDAQ:AMZN), and SAP SE (NYSE:SAP) today unveiled plans to make SAP Sovereign Cloud capabilities available on the AWS European Sovereign Cloud, a new, independent cloud for Europe backed by a planned €7.8 billion investment from Amazon. The collaboration builds on the companies' longstanding partnership and SAP's comprehensive new approach to digital sovereignty and AI innovation. SAP Sovereign Cloud capabilities are security-hardened cloud solutions fro

    9/24/25 3:00:00 AM ET
    $AMZN
    $SAP
    Catalog/Specialty Distribution
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology

    MākuSafe Named 2025 MSD Solutions Lab Safety Innovation Challenge Winner

    Tech innovators present solutions to tackle top workplace injury at NSC Safety Congress & Expo DENVER, Sept. 19, 2025 /PRNewswire/ -- The National Safety Council showcased 10 breakthrough technologies to help prevent musculoskeletal disorders (MSDs) at the fourth annual MSD Solutions Lab Safety Innovation Challenge. Held during the 2025 NSC Safety Congress & Expo, MākuSafe was selected as this year's winner. "MSDs are the leading cause of workplace injuries," said Katherine Mendoza, senior director of workplace safety programs at NSC. "These injuries are preventable, and techn

    9/19/25 3:00:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    SEC Filings

    View All

    SEC Form N-PX filed by Amazon.com Inc.

    N-PX - AMAZON COM INC (0001018724) (Filer)

    8/27/25 4:22:46 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 13F-HR filed by Amazon.com Inc.

    13F-HR - AMAZON COM INC (0001018724) (Filer)

    8/5/25 4:18:54 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 10-Q filed by Amazon.com Inc.

    10-Q - AMAZON COM INC (0001018724) (Filer)

    7/31/25 6:13:08 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    November 14, 2023 - FDA Roundup: November 14, 2023

    For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

    11/14/23 3:26:18 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Stonesifer Patricia Q

    4 - AMAZON COM INC (0001018724) (Issuer)

    9/10/25 6:52:15 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 4 filed by Director Rubinstein Jonathan

    4 - AMAZON COM INC (0001018724) (Issuer)

    9/10/25 6:44:44 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 4 filed by Director Huttenlocher Daniel P

    4 - AMAZON COM INC (0001018724) (Issuer)

    9/10/25 6:37:57 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

    SC 13G/A - AMAZON COM INC (0001018724) (Subject)

    11/8/24 4:33:15 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

    SC 13G/A - AMAZON COM INC (0001018724) (Filed by)

    11/7/24 5:23:12 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SC 13G/A filed by Amazon.com Inc. (Amendment)

    SC 13G/A - AMAZON COM INC (0001018724) (Subject)

    2/13/24 4:55:57 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    Leadership Updates

    Live Leadership Updates

    View All

    eero Celebrates a Decade of Innovation with All-New Wi-Fi 7 Products

    After launching the powerful eero Max 7 and the tough eero Outdoor 7, eero expands Wi-Fi 7 portfolio with all-new eero 7 and eero Pro 7 eero 7 is the company's most affordable Wi-Fi 7 router, offering multi-gigabit speeds in a compact form factor eero Pro 7 delivers premium Wi-Fi 7 performance for high-bandwidth connectivity needs, offering fast wireless and wired speeds with two 5 GbE ports, and capacity for hundreds of devices Amazon (NASDAQ:AMZN) announced that eero is expanding its Wi-Fi 7 portfolio to include eero 7, delivering multi-gigabit speeds at a more affordable price, and eero Pro 7, offering premium performance for bandwidth-demanding networks. Thanks to the company's TrueM

    2/19/25 11:09:00 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    IMDb Announces Leadership Transition as Company Marks 35th Anniversary

    Founder Col Needham Becomes Executive Chair, Nikki Santoro Named CEO, Positioning IMDb for Next Phase of Innovation and Growth IMDb (www.imdb.com), the world's most popular and authoritative source for information on movies, TV shows, and celebrities, today announced that Founder & Chief Executive Officer Col Needham has transitioned to the role of Founder & Executive Chair. Nikki Santoro, who has served as IMDb Chief Operating Officer since 2021, has been appointed the Chief Executive Officer of IMDb. This marks a significant milestone in the company's 35-year history, with Santoro becoming only the second CEO and the first woman to hold the role. This press release features multimedia.

    1/21/25 10:00:00 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Superapp Grab Selects AWS as its Preferred Cloud Provider to Drive Technology Innovation and Growth

    Southeast Asia's leading superapp leverages AWS to enhance operational efficiency across eight countries At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ:AMZN), and Grab, Southeast Asia's leading superapp (NASDAQ:GRAB), announced that Grab has selected AWS as its preferred cloud provider. With AWS, Grab is pursuing a technology-led strategy to accelerate growth across its mobility, deliveries, and financial services verticals, including its new digibanks, while continuing to improve its operational efficiencies and reduce IT infrastructure costs. Grab relies on the world's leading cloud to serve 41.9 million monthly transacting users1 and over 13 mi

    12/4/24 6:30:00 PM ET
    $AMZN
    $GRAB
    Catalog/Specialty Distribution
    Consumer Discretionary
    Real Estate

    $AMZN
    Financials

    Live finance-specific insights

    View All

    Amazon.com Announces Second Quarter Results

    Amazon.com, Inc. (NASDAQ:AMZN) today announced financial results for its second quarter ended June 30, 2025. Net sales increased 13% to $167.7 billion in the second quarter, compared with $148.0 billion in second quarter 2024. Excluding the $1.5 billion favorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 12% compared with second quarter 2024. North America segment sales increased 11% year-over-year to $100.1 billion. International segment sales increased 16% year-over-year to $36.8 billion, or increased 11% excluding changes in foreign exchange rates. AWS segment sales increased 17.5% year-over-year to $30.9 billion.

    7/31/25 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amazon.com to Webcast Second Quarter 2025 Financial Results Conference Call

    Amazon.com, Inc. (NASDAQ:AMZN) announced today that it will hold a conference call to discuss its second quarter 2025 financial results on Thursday, July 31, 2025, at 2:00 p.m. PT/5:00 p.m. ET. The event will be webcast live, and the audio and associated slides will be available for at least three months thereafter at www.amazon.com/ir. View source version on businesswire.com: https://www.businesswire.com/news/home/20250717192665/en/ Amazon.com Public Relations [email protected] amazon.com/ir

    7/17/25 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amazon.com Announces First Quarter Results

    Amazon.com, Inc. (NASDAQ:AMZN) today announced financial results for its first quarter ended March 31, 2025. Net sales increased 9% to $155.7 billion in the first quarter, compared with $143.3 billion in first quarter 2024. Excluding the $1.4 billion unfavorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 10% compared with first quarter 2024. North America segment sales increased 8% year-over-year to $92.9 billion. International segment sales increased 5% year-over-year to $33.5 billion, or increased 8% excluding changes in foreign exchange rates. AWS segment sales increased 17% year-over-year to $29.3 billion. Operati

    5/1/25 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary